Andrew S Azman
Overview
Explore the profile of Andrew S Azman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
178
Citations
7679
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koyuncu A, Asilaza K, Rumunu J, Wamala J, Gitahi P, Antier Z, et al.
PLOS Glob Public Health
. 2025 Mar;
5(3):e0003482.
PMID: 40048457
In 2021 in response to an outbreak of hepatitis E in Bentiu internally displaced persons camp the South Sudanese Ministry of Health with support from Médecins Sans Frontières implemented the...
2.
Koyuncu A, Bugeme P, Dent J, Hutchins C, Xu H, Gallandat K, et al.
BMJ Public Health
. 2025 Feb;
3(1):e001035.
PMID: 40017972
Background: We conducted three serial cross-sectional representative surveys after a mass cholera vaccination campaign in Uvira, Democratic Republic of the Congo to (1) estimate the vaccination coverage and explore heterogeneity...
3.
Ngomtcho S, Akenji B, Ndip R, Azman A, Tayimetha Y, Guenou E, et al.
PLOS Glob Public Health
. 2025 Feb;
5(2):e0003763.
PMID: 39992999
Seventh pandemic Vibrio cholerae was first identified in Cameroon in 1971, causing several sporadic disease clusters with few cases. More recent years have seen larger cholera outbreaks, but the mechanism...
4.
Bugeme P, Bugale P, Mashauri J, Kapalata A, Bugwaja L, Mukika T, et al.
Lancet Infect Dis
. 2025 Jan;
25(3):e124-e125.
PMID: 39862871
No abstract available.
5.
Nesbitt R, Kinya Asilaza V, Alvarez C, Gitahi P, Nkemenang P, Duncker J, et al.
Lancet Infect Dis
. 2025 Jan;
PMID: 39798583
Background: Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis, particularly in Asia and Africa, where HEV genotypes 1 and 2 are prevalent. Although a recombinant vaccine,...
6.
Rhee C, Dighe A, Katuwal N, Cho H, Mraidi R, Tamrakar D, et al.
PLoS Negl Trop Dis
. 2024 Dec;
18(12):e0012746.
PMID: 39715282
Background: Hepatitis E virus (HEV) causes acute jaundice and poses an important public health problem in low- and middle-income countries. Limited surveillance capacity and suboptimal access to diagnostics leads to...
7.
Wiens K, Miller M, Costello D, Solomon A, Hilbert S, Shipper A, et al.
medRxiv
. 2024 Dec;
PMID: 39711701
Background: Monitoring and treating diarrheal illness often rely on individuals seeking care at hospitals or clinics. Cases that seek care through pharmacies and community health workers (CHW) are frequently excluded...
8.
Finger F, Lemaitre J, Juin S, Jackson B, Funk S, Lessler J, et al.
Epidemiol Infect
. 2024 Dec;
152:e149.
PMID: 39618115
Most infections with pandemic are thought to result in subclinical disease and are not captured by surveillance. Previous estimates of the ratio of infections to clinical cases have varied widely...
9.
Nesbitt R, Azman A, Kinya Asilaza V, Edwards J, Gitahi P, Nkemenang P, et al.
Lancet Glob Health
. 2024 Oct;
12(11):e1881-e1890.
PMID: 39424575
Background: Epidemic forms of hepatitis E cause high mortality among pregnant people, with case fatality risks over 30% and adverse fetal outcomes. In 2022, the first mass reactive vaccination campaign...
10.
McKee C, Yu E, Garcia A, Jackson J, Koyuncu A, Rose S, et al.
Epidemiol Infect
. 2024 Oct;
152:e121.
PMID: 39377138
SARS-CoV-2 superspreading occurs when transmission is highly efficient and/or an individual infects many others, contributing to rapid spread. To better quantify heterogeneity in SARS-CoV-2 transmission, particularly superspreading, we performed a...